Shenzhen Lifotronic Technology Co Cash Flow Conversion Efficiency

Latest as of September 2025: 0.025x

Shenzhen Lifotronic Technology Co cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has a cash flow conversion efficiency ratio of 0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥53.10 Million ≈ $7.77 Million USD) by net assets (CN¥2.10 Billion ≈ $306.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shenzhen Lifotronic Technology Co (2016–2025)

Cash flow conversion efficiency of Shenzhen Lifotronic Technology Co from 2016 to 2025. This chart illustrates how Shenzhen Lifotronic Technology Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shenzhen Lifotronic Technology Co share price for real-time trading data and today's change.

Shenzhen Lifotronic Technology Co Cash Flow Conversion Ratio Explained

Shenzhen Lifotronic Technology Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shenzhen Lifotronic Technology Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their cash flow conversion efficiency. Also see 688389 company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
ADITYA VISION LTD
NSE:AVL
0.197x
Arrowhead Properties Ltd B
JSE:FTB
0.046x
BW Offshore Ltd
OL:BWO
0.348x
SGSG Science&technology Co Ltd Zhuhai
SHE:300561
0.008x
Anhui Coreach Technology Co Ltd
SHE:002983
0.067x
Nanjing Kangni Mechanical & Electrical Co Ltd
SHG:603111
0.013x
TPK Holding Co Ltd
TW:3673
-0.008x
Sapphire Foods India Limited
NSE:SAPPHIRE
0.153x

Annual Cash Flow Conversion Efficiency for Shenzhen Lifotronic Technology Co (2016–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Lifotronic Technology Co from 2016 to 2025. Review Shenzhen Lifotronic Technology Co free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.11 Billion
≈ $308.57 Million
CN¥280.97 Million
≈ $41.11 Million
0.133x -7.90%
2024-12-31 CN¥2.05 Billion
≈ $299.89 Million
CN¥296.47 Million
≈ $43.38 Million
0.145x -14.41%
2023-12-31 CN¥1.80 Billion
≈ $263.05 Million
CN¥303.82 Million
≈ $44.46 Million
0.169x -10.21%
2022-12-31 CN¥1.44 Billion
≈ $211.23 Million
CN¥271.71 Million
≈ $39.76 Million
0.188x +30.06%
2021-12-31 CN¥1.26 Billion
≈ $184.08 Million
CN¥182.07 Million
≈ $26.64 Million
0.145x +21.33%
2020-12-31 CN¥1.14 Billion
≈ $167.34 Million
CN¥136.42 Million
≈ $19.96 Million
0.119x +36.36%
2019-12-31 CN¥1.05 Billion
≈ $153.60 Million
CN¥91.82 Million
≈ $13.44 Million
0.087x -27.94%
2018-12-31 CN¥668.39 Million
≈ $97.81 Million
CN¥81.14 Million
≈ $11.87 Million
0.121x +102.24%
2017-12-31 CN¥587.25 Million
≈ $85.93 Million
CN¥35.25 Million
≈ $5.16 Million
0.060x -20.50%
2016-12-31 CN¥370.82 Million
≈ $54.26 Million
CN¥28.00 Million
≈ $4.10 Million
0.076x --

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices
Market Cap
$731.09 Million
CN¥5.00 Billion CNY
Market Cap Rank
#9979 Global
#2598 in China
Share Price
CN¥11.66
Change (1 day)
-2.26%
52-Week Range
CN¥9.59 - CN¥14.38
All Time High
CN¥37.22
About

Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blo… Read more